Palvella Therapeutics Inc.
XNAS: PVLA
Palvella Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...
Read More
37.44
-1.44
(-3.70%)
256.9K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Palvella Therapeutics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..